Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment
出版年份 2019 全文链接
标题
Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment
作者
关键词
-
出版物
Expert Opinion On Drug Safety
Volume -, Issue -, Pages 1-12
出版商
Informa UK Limited
发表日期
2019-07-15
DOI
10.1080/14740338.2019.1644317
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients
- (2019) J.-P. Bastard et al. DIABETES & METABOLISM
- Impact of HIV/SIV infection and viral proteins on adipose tissue fibrosis and adipogenesis
- (2019) Jennifer Gorwood et al. AIDS
- Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study
- (2019) Christine Katlama et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Incidence and Risk Factors for Prediabetes and Diabetes Mellitus Among HIV-infected Adults on Antiretroviral Therapy
- (2018) Jobert Richie Nansseu et al. EPIDEMIOLOGY
- Metabolic syndrome in human immunodeficiency virus-infected patients
- (2018) M Duro et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors
- (2018) David R Bakal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Histological and Molecular Adipose Tissue Changes Are Related to Metabolic Syndrome Rather Than Lipodystrophy in Human Immunodeficiency Virus-Infected Patients: A Cross-Sectional Study
- (2018) Anne Langkilde et al. JOURNAL OF INFECTIOUS DISEASES
- The Effect of Bariatric Surgery on Patients with HIV Infection: a Literature Review
- (2018) Khalid Akbari et al. OBESITY SURGERY
- Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives
- (2018) Corinne Vigouroux et al. Nucleus
- Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives
- (2018) Corinne Vigouroux et al. Nucleus
- Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy
- (2018) Vanessa El Kamari et al. CLINICAL INFECTIOUS DISEASES
- Prior exposure to thymidine analogues and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors
- (2018) Marco Gelpi et al. AIDS
- Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observ
- (2018) G Baldin et al. HIV MEDICINE
- Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients
- (2018) Leonardo Calza et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Metabolic risk factors in young adults infected with HIV since childhood compared with the general population
- (2018) Elise Arrive et al. PLoS One
- Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia
- (2017) P Echeverría et al. HIV MEDICINE
- Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis
- (2017) Jose Echecopar-Sabogal et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study
- (2016) Anne-Laurence Tomi et al. ANNALS OF THE RHEUMATIC DISEASES
- An open-label, randomized study of the impact on insulin sensitivity, lipid profile and vascular inflammation by treatment with lopinavir/ritonavir or raltegravir in HIV-negative male volunteers
- (2016) Paul Randell et al. ANTIVIRAL THERAPY
- Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers: results from the STRIBILD-IR study
- (2016) Christoph D Spinner et al. ANTIVIRAL THERAPY
- LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation
- (2016) Pauline Afonso et al. ATHEROSCLEROSIS
- Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s
- (2016) Grace A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure
- (2016) Rosan A. van Zoest et al. CLINICAL INFECTIOUS DISEASES
- Integrase strand transfer inhibitor-associated diabetes mellitus: A case report
- (2016) Peter S Fong et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Dysfunctional Subcutaneous Fat With Reduced Dicer and Brown Adipose Tissue Gene Expression in HIV-Infected Patients
- (2016) Martin Torriani et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
- (2016) Sumanth Karamchand et al. MEDICINE
- Naringin protects against HIV-1 protease inhibitors-induced pancreatic β-cell dysfunction and apoptosis
- (2016) Sanelisiwe Nzuza et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s
- (2016) Sahera Dirajlal-Fargo et al. Open Forum Infectious Diseases
- A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population
- (2016) Kim A. Nguyen et al. PLoS One
- Human adipose tissue as a reservoir for memory CD4+ T cells and HIV
- (2015) Jacob Couturier et al. AIDS
- Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients
- (2015) Pierre Duffau et al. AIDS
- Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks
- (2015) Romina Quercia et al. CLINICAL DRUG INVESTIGATION
- The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial
- (2015) José R. Santos et al. CLINICAL INFECTIOUS DISEASES
- New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand
- (2015) Prakit Riyaten et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The Molecular Signature of HIV-1-Associated Lipomatosis Reveals Differential Involvement of Brown and Beige/Brite Adipocyte Cell Lineages
- (2015) Rubén Cereijo et al. PLoS One
- Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection
- (2015) Abderaouf Damouche et al. PLoS Pathogens
- Risk Factors for Fatty Liver in the Multicenter AIDS Cohort Study
- (2014) Jennifer C Price et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mitochondrial DNA mutations in ageing and disease: implications for HIV?
- (2014) Brendan AI Payne et al. ANTIVIRAL THERAPY
- Impact of darunavir, atazanavir and lopinavir boosted with ritonavir on cultured human endothelial cells: beneficial effect of pravastatin
- (2014) Martine Auclair et al. ANTIVIRAL THERAPY
- Lipid Levels and Changes in Body Fat Distribution in Treatment-Naive, HIV-1–Infected Adults Treated With Rilpivirine or Efavirenz for 96 Weeks in the ECHO and THRIVE Trials
- (2014) Pablo Tebas et al. CLINICAL INFECTIOUS DISEASES
- Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
- (2014) J. Schouten et al. CLINICAL INFECTIOUS DISEASES
- Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study
- (2014) C. Katlama et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification of Cardiometabolic Risk: Visceral Adiposity Index Versus Triglyceride/HDL Cholesterol Ratio
- (2013) Martin R. Salazar et al. AMERICAN JOURNAL OF MEDICINE
- CD8 T-Cell Activation Is Associated With Lipodystrophy and Visceral Fat Accumulation in Antiretroviral Therapy–Treated Virologically Suppressed HIV-Infected Patients
- (2013) Giovanni Guaraldi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV and Coronary Heart Disease
- (2013) Franck Boccara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens
- (2012) Alba Bigoloni et al. AIDS
- Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
- (2012) Esteban Martínez et al. AIDS
- Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy
- (2012) Laura Galli et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Mitochondrial DNA Haplogroups and Incidence of Lipodystrophy in HIV-Infected Patients on Long-Term Antiretroviral Therapy
- (2012) Andrea De Luca et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Adipogenic/Lipid, Inflammatory, and Mitochondrial Parameters in Subcutaneous Adipose Tissue of Untreated HIV-1–Infected Long-Term Nonprogressors
- (2012) Francesc Vidal et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study
- (2012) Line D. Rasmussen et al. PLoS One
- Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment
- (2011) Jacqueline Capeau et al. AIDS
- LMNA Mutations Induce a Non-Inflammatory Fibrosis and a Brown Fat-Like Dystrophy of Enlarged Cervical Adipose Tissue
- (2011) Véronique Béréziat et al. AMERICAN JOURNAL OF PATHOLOGY
- Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines
- (2011) Julieta Díaz-Delfín et al. ANTIVIRAL RESEARCH
- Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes
- (2011) Emilie Capel et al. ANTIVIRAL THERAPY
- Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial
- (2011) G. Fatkenheuer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome
- (2010) Signe W Worm et al. AIDS
- Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected Patients Under Antiretroviral Treatment
- (2010) Marta Giralt et al. CURRENT PHARMACEUTICAL DESIGN
- HIV-associated lipodystrophy: from fat injury to premature aging
- (2010) Martine Caron-Debarle et al. TRENDS IN MOLECULAR MEDICINE
- Protease inhibitors used in the treatment of HIV+ induce β-cell apoptosis via the mitochondrial pathway and compromise insulin secretion
- (2009) Sheng Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Drug-induced lipotoxicity: Lipodystrophy associated with HIV-1 infection and antiretroviral treatment
- (2009) Francesc Villarroya et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Effects of First-Line Use of Nucleoside Analogues, Efavirenz, and Ritonavir-Boosted Protease Inhibitors on Lipid Levels
- (2009) Andrew Hill et al. HIV CLINICAL TRIALS
- Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons
- (2009) Nancy Crum-Cianflone et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors
- (2008) Giovanni Guaraldi et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now